NCT07578610 Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome Platform
| NCT ID | NCT07578610 |
| Status | Recruiting |
| Phase | — |
| Sponsor | OpenGenome |
| Condition | Signs and Symptoms |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2026-05-05 |
| Primary Completion | 2028-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2026-05-05 with a primary completion date of 2028-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registry prospectively collects anonymized free-text symptom descriptions submitted voluntarily by adults through the OpenGenome platform at opengenome.bio. For each submission, the system retrieves real biomedical literature from PubMed and ClinicalTrials.gov in parallel, applies a constrained reasoning model operating under a strict output schema, and returns a structured biological signal report. The study evaluates the internal consistency of extracted signals, the calibration of confidence scores relative to dataset size and symptom specificity, and the distribution of biological signal categories across a large anonymous population. No intervention is assigned. No participant contact occurs. All data is anonymized at the point of collection.
Eligibility Criteria
* Automated or programmatically generated submissions detected by rate limiting * Submissions containing no discernible symptom or health-related content
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07578610 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Signs and Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07578610 currently recruiting?
Yes, NCT07578610 is actively recruiting participants. Contact the research team at richard@opengenome.bio for enrollment information.
Where is the NCT07578610 trial being conducted?
This trial is being conducted at Friedrichshain, Germany.
Who is sponsoring the NCT07578610 clinical trial?
NCT07578610 is sponsored by OpenGenome. The trial plans to enroll 1,000 participants.